Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07363096

Single- Versus Two-Level ESP Block for Analgesia After Lumbar Stabilization Surgery

Comparison Of Single- Versus Two-Level Erector Spinae Plane Block For Postoperative Analgesia In Patients Undergoing Lumbar Stabilization Surgery

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Ankara Etlik City Hospital · Other Government
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Lumbar stabilization surgery is commonly associated with moderate to severe postoperative pain. Effective pain control is important to improve patient comfort, early mobilization, and recovery. The erector spinae plane (ESP) block is a regional anesthesia technique that has been increasingly used for postoperative pain management in spine surgery. This study aims to compare the effectiveness of single-level versus two-level ultrasound-guided ESP block for postoperative pain control in patients undergoing lumbar stabilization surgery. Patients will be randomly assigned to receive either a single-level ESP block or a two-level ESP block in addition to standard analgesic treatment. Postoperative pain scores, opioid consumption, and the incidence of side effects will be evaluated during the postoperative period. The results of this study may help determine the most effective ESP block technique for pain management after lumbar stabilization surgery.

Conditions

Interventions

TypeNameDescription
PROCEDURESingle-Level Erector Spinae Plane BlockUltrasound-guided erector spinae plane block performed at a single vertebral level for postoperative analgesia.
PROCEDURETwo-Level Erector Spinae Plane BlockUltrasound-guided erector spinae plane block performed at two adjacent vertebral levels for postoperative analgesia.

Timeline

Start date
2026-02-01
Primary completion
2027-01-01
Completion
2027-01-03
First posted
2026-01-23
Last updated
2026-01-23

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07363096. Inclusion in this directory is not an endorsement.